477 related articles for article (PubMed ID: 30279553)
1. Arrowtail RNA for Ligand Display on Ginger Exosome-like Nanovesicles to Systemic Deliver siRNA for Cancer Suppression.
Li Z; Wang H; Yin H; Bennett C; Zhang HG; Guo P
Sci Rep; 2018 Oct; 8(1):14644. PubMed ID: 30279553
[TBL] [Abstract][Full Text] [Related]
2. Cell-free synthesis of connexin 43-integrated exosome-mimetic nanoparticles for siRNA delivery.
Lu M; Zhao X; Xing H; Liu H; Lang L; Yang T; Xun Z; Wang D; Ding P
Acta Biomater; 2019 Sep; 96():517-536. PubMed ID: 31284098
[TBL] [Abstract][Full Text] [Related]
3. Folate-displaying exosome mediated cytosolic delivery of siRNA avoiding endosome trapping.
Zheng Z; Li Z; Xu C; Guo B; Guo P
J Control Release; 2019 Oct; 311-312():43-49. PubMed ID: 31446085
[TBL] [Abstract][Full Text] [Related]
4. Low-weight polyethylenimine cross-linked 2-hydroxypopyl-β-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA.
Li JM; Wang YY; Zhang W; Su H; Ji LN; Mao ZW
Int J Nanomedicine; 2013; 8():2101-17. PubMed ID: 23766646
[TBL] [Abstract][Full Text] [Related]
5. Milk exosomes - Natural nanoparticles for siRNA delivery.
Aqil F; Munagala R; Jeyabalan J; Agrawal AK; Kyakulaga AH; Wilcher SA; Gupta RC
Cancer Lett; 2019 May; 449():186-195. PubMed ID: 30771430
[TBL] [Abstract][Full Text] [Related]
6. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
7. Oral administration of ginger-derived nanolipids loaded with siRNA as a novel approach for efficient siRNA drug delivery to treat ulcerative colitis.
Zhang M; Wang X; Han MK; Collins JF; Merlin D
Nanomedicine (Lond); 2017 Aug; 12(16):1927-1943. PubMed ID: 28665164
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors.
Wang J; Lu Z; Wang J; Cui M; Yeung BZ; Cole DJ; Wientjes MG; Au JL
J Control Release; 2015 Oct; 216():103-10. PubMed ID: 26272765
[TBL] [Abstract][Full Text] [Related]
9. Safe and Targeted Sonodynamic Cancer Therapy Using Biocompatible Exosome-Based Nanosonosensitizers.
Nguyen Cao TG; Kang JH; You JY; Kang HC; Rhee WJ; Ko YT; Shim MS
ACS Appl Mater Interfaces; 2021 Jun; 13(22):25575-25588. PubMed ID: 34033477
[TBL] [Abstract][Full Text] [Related]
10. Exosomes-coated bcl-2 siRNA inhibits the growth of digestive system tumors both in vitro and in vivo.
Tao H; Xu H; Zuo L; Li C; Qiao G; Guo M; Zheng L; Leitgeb M; Lin X
Int J Biol Macromol; 2020 Oct; 161():470-480. PubMed ID: 32531356
[TBL] [Abstract][Full Text] [Related]
11. Folic acid-decorated polyamidoamine dendrimer exhibits high tumor uptake and sustained highly localized retention in solid tumors: Its utility for local siRNA delivery.
Xu L; Yeudall WA; Yang H
Acta Biomater; 2017 Jul; 57():251-261. PubMed ID: 28438704
[TBL] [Abstract][Full Text] [Related]
12. Engineering Exosome-Like Nanovesicles Derived from
Zhang L; He F; Gao L; Cong M; Sun J; Xu J; Wang Y; Hu Y; Asghar S; Hu L; Qiao H
Int J Nanomedicine; 2021; 16():1575-1586. PubMed ID: 33664572
[TBL] [Abstract][Full Text] [Related]
13. Delivery of Small Interfering RNA to Inhibit Vascular Endothelial Growth Factor in Zebrafish Using Natural Brain Endothelia Cell-Secreted Exosome Nanovesicles for the Treatment of Brain Cancer.
Yang T; Fogarty B; LaForge B; Aziz S; Pham T; Lai L; Bai S
AAPS J; 2017 Mar; 19(2):475-486. PubMed ID: 27882487
[TBL] [Abstract][Full Text] [Related]
14. Self-assembled nanoparticles based on the c(RGDfk) peptide for the delivery of siRNA targeting the VEGFR2 gene for tumor therapy.
Liu L; Liu X; Xu Q; Wu P; Zuo X; Zhang J; Deng H; Wu Z; Ji A
Int J Nanomedicine; 2014; 9():3509-26. PubMed ID: 25114522
[TBL] [Abstract][Full Text] [Related]
15. Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts.
Yoshizawa T; Hattori Y; Hakoshima M; Koga K; Maitani Y
Eur J Pharm Biopharm; 2008 Nov; 70(3):718-25. PubMed ID: 18647651
[TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of endothelial exosomes as carriers for small interfering ribonucleic acid delivery.
Banizs AB; Huang T; Dryden K; Berr SS; Stone JR; Nakamoto RK; Shi W; He J
Int J Nanomedicine; 2014; 9():4223-30. PubMed ID: 25214786
[TBL] [Abstract][Full Text] [Related]
17. Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors.
Jang SC; Kim OY; Yoon CM; Choi DS; Roh TY; Park J; Nilsson J; Lötvall J; Kim YK; Gho YS
ACS Nano; 2013 Sep; 7(9):7698-710. PubMed ID: 24004438
[TBL] [Abstract][Full Text] [Related]
18. One-Step Production Using a Microfluidic Device of Highly Biocompatible Size-Controlled Noncationic Exosome-like Nanoparticles for RNA Delivery.
Kimura N; Maeki M; Ishida A; Tani H; Tokeshi M
ACS Appl Bio Mater; 2021 Feb; 4(2):1783-1793. PubMed ID: 35014524
[TBL] [Abstract][Full Text] [Related]
19. Nanoscale polysaccharide derivative as an AEG-1 siRNA carrier for effective osteosarcoma therapy.
Wang F; Pang JD; Huang LL; Wang R; Li D; Sun K; Wang LT; Zhang LM
Int J Nanomedicine; 2018; 13():857-875. PubMed ID: 29467575
[TBL] [Abstract][Full Text] [Related]
20. Post-PEGylation of siRNA Lipo-oligoamino Amide Polyplexes Using Tetra-glutamylated Folic Acid as Ligand for Receptor-Targeted Delivery.
Müller K; Kessel E; Klein PM; Höhn M; Wagner E
Mol Pharm; 2016 Jul; 13(7):2332-45. PubMed ID: 27177200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
